nodes	percent_of_prediction	percent_of_DWPC	metapath
Fingolimod—CYP2D6—Progesterone—uterine cancer	0.0647	0.232	CbGbCtD
Fingolimod—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0621	0.222	CbGbCtD
Fingolimod—CYP2E1—Etoposide—uterine cancer	0.0607	0.217	CbGbCtD
Fingolimod—CYP3A4—Progesterone—uterine cancer	0.0411	0.147	CbGbCtD
Fingolimod—CYP2D6—Doxorubicin—uterine cancer	0.0197	0.0707	CbGbCtD
Fingolimod—CYP3A4—Etoposide—uterine cancer	0.0184	0.0659	CbGbCtD
Fingolimod—CYP3A4—Doxorubicin—uterine cancer	0.0126	0.0449	CbGbCtD
Fingolimod—Macular oedema—Medroxyprogesterone Acetate—uterine cancer	0.0117	0.0609	CcSEcCtD
Fingolimod—SPHK1—myometrium—uterine cancer	0.0107	0.0393	CbGeAlD
Fingolimod—CYP4F12—myometrium—uterine cancer	0.0103	0.0377	CbGeAlD
Fingolimod—CYP4F2—renal system—uterine cancer	0.0101	0.037	CbGeAlD
Fingolimod—CYP4F2—mammalian vulva—uterine cancer	0.00941	0.0346	CbGeAlD
Fingolimod—S1PR3—smooth muscle tissue—uterine cancer	0.00927	0.0341	CbGeAlD
Fingolimod—S1PR3—decidua—uterine cancer	0.00909	0.0334	CbGeAlD
Fingolimod—S1PR5—female reproductive system—uterine cancer	0.0086	0.0316	CbGeAlD
Fingolimod—S1PR1—epithelium—uterine cancer	0.00848	0.0312	CbGeAlD
Fingolimod—S1PR1—smooth muscle tissue—uterine cancer	0.00817	0.03	CbGeAlD
Fingolimod—SPHK1—smooth muscle tissue—uterine cancer	0.00809	0.0297	CbGeAlD
Fingolimod—S1PR1—decidua—uterine cancer	0.00801	0.0294	CbGeAlD
Fingolimod—CYP4F12—uterine cervix—uterine cancer	0.008	0.0294	CbGeAlD
Fingolimod—SPHK1—decidua—uterine cancer	0.00793	0.0291	CbGeAlD
Fingolimod—SPHK1—renal system—uterine cancer	0.00779	0.0286	CbGeAlD
Fingolimod—SPHK1—endometrium—uterine cancer	0.00753	0.0276	CbGeAlD
Fingolimod—CYP4F2—vagina—uterine cancer	0.00729	0.0268	CbGeAlD
Fingolimod—SPHK1—mammalian vulva—uterine cancer	0.00728	0.0267	CbGeAlD
Fingolimod—CYP4F12—endometrium—uterine cancer	0.00723	0.0266	CbGeAlD
Fingolimod—S1PR3—female reproductive system—uterine cancer	0.00715	0.0263	CbGeAlD
Fingolimod—CYP4F12—mammalian vulva—uterine cancer	0.007	0.0257	CbGeAlD
Fingolimod—SPHK1—uterus—uterine cancer	0.00694	0.0255	CbGeAlD
Fingolimod—CYP4F12—uterus—uterine cancer	0.00666	0.0245	CbGeAlD
Fingolimod—S1PR3—female gonad—uterine cancer	0.0065	0.0239	CbGeAlD
Fingolimod—S1PR1—female reproductive system—uterine cancer	0.0063	0.0231	CbGeAlD
Fingolimod—SPHK1—female reproductive system—uterine cancer	0.00624	0.0229	CbGeAlD
Fingolimod—CYP4F12—female reproductive system—uterine cancer	0.00599	0.022	CbGeAlD
Fingolimod—S1PR4—lymph node—uterine cancer	0.00599	0.022	CbGeAlD
Fingolimod—S1PR1—female gonad—uterine cancer	0.00573	0.0211	CbGeAlD
Fingolimod—S1PR1—vagina—uterine cancer	0.0057	0.0209	CbGeAlD
Fingolimod—SPHK1—female gonad—uterine cancer	0.00567	0.0208	CbGeAlD
Fingolimod—SPHK1—vagina—uterine cancer	0.00564	0.0207	CbGeAlD
Fingolimod—CYP4F12—female gonad—uterine cancer	0.00545	0.02	CbGeAlD
Fingolimod—CYP4F12—vagina—uterine cancer	0.00542	0.0199	CbGeAlD
Fingolimod—Cerebral haemorrhage—Medroxyprogesterone Acetate—uterine cancer	0.00518	0.0268	CcSEcCtD
Fingolimod—S1PR5—lymph node—uterine cancer	0.00503	0.0185	CbGeAlD
Fingolimod—S1PR3—lymph node—uterine cancer	0.00418	0.0154	CbGeAlD
Fingolimod—Gamma-glutamyltransferase increased—Progesterone—uterine cancer	0.00385	0.0199	CcSEcCtD
Fingolimod—S1PR1—lymph node—uterine cancer	0.00369	0.0135	CbGeAlD
Fingolimod—SPHK1—lymph node—uterine cancer	0.00365	0.0134	CbGeAlD
Fingolimod—CYP4F12—lymph node—uterine cancer	0.0035	0.0129	CbGeAlD
Fingolimod—Hepatic enzyme increased—Progesterone—uterine cancer	0.00335	0.0173	CcSEcCtD
Fingolimod—Gastroenteritis—Progesterone—uterine cancer	0.00259	0.0134	CcSEcCtD
Fingolimod—Migraine—Progesterone—uterine cancer	0.00226	0.0117	CcSEcCtD
Fingolimod—Infection—Carboplatin—uterine cancer	0.00214	0.0111	CcSEcCtD
Fingolimod—Cerebrovascular accident—Medroxyprogesterone Acetate—uterine cancer	0.00212	0.011	CcSEcCtD
Fingolimod—Liver function test abnormal—Progesterone—uterine cancer	0.00212	0.011	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Progesterone—uterine cancer	0.00207	0.0107	CcSEcCtD
Fingolimod—Migraine—Medroxyprogesterone Acetate—uterine cancer	0.00205	0.0106	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Progesterone—uterine cancer	0.00203	0.0105	CcSEcCtD
Fingolimod—Bronchitis—Progesterone—uterine cancer	0.00191	0.0099	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Medroxyprogesterone Acetate—uterine cancer	0.00184	0.00952	CcSEcCtD
Fingolimod—Influenza—Medroxyprogesterone Acetate—uterine cancer	0.0018	0.00933	CcSEcCtD
Fingolimod—Weight decreased—Progesterone—uterine cancer	0.0018	0.00931	CcSEcCtD
Fingolimod—Pneumonia—Progesterone—uterine cancer	0.00178	0.00923	CcSEcCtD
Fingolimod—Lymphopenia—Epirubicin—uterine cancer	0.00177	0.00919	CcSEcCtD
Fingolimod—Infestation NOS—Progesterone—uterine cancer	0.00177	0.00918	CcSEcCtD
Fingolimod—Infestation—Progesterone—uterine cancer	0.00177	0.00918	CcSEcCtD
Fingolimod—Depression—Progesterone—uterine cancer	0.00177	0.00915	CcSEcCtD
Fingolimod—Bronchitis—Medroxyprogesterone Acetate—uterine cancer	0.00173	0.00897	CcSEcCtD
Fingolimod—Sinusitis—Progesterone—uterine cancer	0.00166	0.00861	CcSEcCtD
Fingolimod—Lymphopenia—Doxorubicin—uterine cancer	0.00164	0.00851	CcSEcCtD
Fingolimod—Weight decreased—Medroxyprogesterone Acetate—uterine cancer	0.00163	0.00844	CcSEcCtD
Fingolimod—Infestation—Medroxyprogesterone Acetate—uterine cancer	0.0016	0.00832	CcSEcCtD
Fingolimod—Infestation NOS—Medroxyprogesterone Acetate—uterine cancer	0.0016	0.00832	CcSEcCtD
Fingolimod—Depression—Medroxyprogesterone Acetate—uterine cancer	0.0016	0.00829	CcSEcCtD
Fingolimod—Connective tissue disorder—Progesterone—uterine cancer	0.00156	0.0081	CcSEcCtD
Fingolimod—Sinusitis—Medroxyprogesterone Acetate—uterine cancer	0.0015	0.0078	CcSEcCtD
Fingolimod—Liver function test abnormal—Dactinomycin—uterine cancer	0.0015	0.00777	CcSEcCtD
Fingolimod—Eye disorder—Progesterone—uterine cancer	0.00149	0.0077	CcSEcCtD
Fingolimod—Cardiac disorder—Progesterone—uterine cancer	0.00147	0.00765	CcSEcCtD
Fingolimod—Bradycardia—Medroxyprogesterone Acetate—uterine cancer	0.00147	0.0076	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Dactinomycin—uterine cancer	0.00146	0.00758	CcSEcCtD
Fingolimod—Angiopathy—Progesterone—uterine cancer	0.00144	0.00747	CcSEcCtD
Fingolimod—Mediastinal disorder—Progesterone—uterine cancer	0.00143	0.00742	CcSEcCtD
Fingolimod—Connective tissue disorder—Medroxyprogesterone Acetate—uterine cancer	0.00142	0.00734	CcSEcCtD
Fingolimod—Alopecia—Progesterone—uterine cancer	0.0014	0.00728	CcSEcCtD
Fingolimod—Mental disorder—Progesterone—uterine cancer	0.00139	0.00722	CcSEcCtD
Fingolimod—Eye disorder—Medroxyprogesterone Acetate—uterine cancer	0.00135	0.00698	CcSEcCtD
Fingolimod—Back pain—Progesterone—uterine cancer	0.00134	0.00694	CcSEcCtD
Fingolimod—Cardiac disorder—Medroxyprogesterone Acetate—uterine cancer	0.00134	0.00693	CcSEcCtD
Fingolimod—Angiopathy—Medroxyprogesterone Acetate—uterine cancer	0.00131	0.00677	CcSEcCtD
Fingolimod—Vision blurred—Progesterone—uterine cancer	0.0013	0.00676	CcSEcCtD
Fingolimod—Mediastinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.0013	0.00673	CcSEcCtD
Fingolimod—Alopecia—Medroxyprogesterone Acetate—uterine cancer	0.00127	0.0066	CcSEcCtD
Fingolimod—Mental disorder—Medroxyprogesterone Acetate—uterine cancer	0.00126	0.00654	CcSEcCtD
Fingolimod—CYP2E1—renal system—uterine cancer	0.00126	0.00463	CbGeAlD
Fingolimod—Pneumonia—Dactinomycin—uterine cancer	0.00126	0.00652	CcSEcCtD
Fingolimod—Palpitations—Progesterone—uterine cancer	0.00122	0.00634	CcSEcCtD
Fingolimod—Back pain—Medroxyprogesterone Acetate—uterine cancer	0.00121	0.00629	CcSEcCtD
Fingolimod—Cough—Progesterone—uterine cancer	0.00121	0.00626	CcSEcCtD
Fingolimod—Herpes zoster—Epirubicin—uterine cancer	0.00121	0.00625	CcSEcCtD
Fingolimod—Hypertension—Progesterone—uterine cancer	0.00119	0.00619	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.00117	0.00606	CcSEcCtD
Fingolimod—Infection—Progesterone—uterine cancer	0.00112	0.00581	CcSEcCtD
Fingolimod—Cardiac arrest—Etoposide—uterine cancer	0.00112	0.00579	CcSEcCtD
Fingolimod—Herpes zoster—Doxorubicin—uterine cancer	0.00112	0.00578	CcSEcCtD
Fingolimod—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.00111	0.00574	CcSEcCtD
Fingolimod—Nervous system disorder—Progesterone—uterine cancer	0.00111	0.00574	CcSEcCtD
Fingolimod—Skin disorder—Progesterone—uterine cancer	0.0011	0.00569	CcSEcCtD
Fingolimod—Liver injury—Epirubicin—uterine cancer	0.00108	0.00559	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.00106	0.00549	CcSEcCtD
Fingolimod—Hypotension—Progesterone—uterine cancer	0.00105	0.00547	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Etoposide—uterine cancer	0.00104	0.00537	CcSEcCtD
Fingolimod—Infection—Medroxyprogesterone Acetate—uterine cancer	0.00102	0.00527	CcSEcCtD
Fingolimod—CYP3A4—renal system—uterine cancer	0.00102	0.00373	CbGeAlD
Fingolimod—Paraesthesia—Progesterone—uterine cancer	0.00101	0.00526	CcSEcCtD
Fingolimod—CYP2E1—female reproductive system—uterine cancer	0.00101	0.00371	CbGeAlD
Fingolimod—Dyspnoea—Progesterone—uterine cancer	0.00101	0.00522	CcSEcCtD
Fingolimod—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.001	0.0052	CcSEcCtD
Fingolimod—CYP2D6—renal system—uterine cancer	0.000999	0.00367	CbGeAlD
Fingolimod—Liver injury—Doxorubicin—uterine cancer	0.000998	0.00517	CcSEcCtD
Fingolimod—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.000994	0.00515	CcSEcCtD
Fingolimod—Alopecia—Dactinomycin—uterine cancer	0.000993	0.00515	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Progesterone—uterine cancer	0.000975	0.00505	CcSEcCtD
Fingolimod—Fatigue—Progesterone—uterine cancer	0.000973	0.00505	CcSEcCtD
Fingolimod—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.000956	0.00496	CcSEcCtD
Fingolimod—Atrioventricular block—Epirubicin—uterine cancer	0.000935	0.00485	CcSEcCtD
Fingolimod—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.000919	0.00476	CcSEcCtD
Fingolimod—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.000912	0.00473	CcSEcCtD
Fingolimod—Pneumonia—Etoposide—uterine cancer	0.000911	0.00472	CcSEcCtD
Fingolimod—Infestation NOS—Etoposide—uterine cancer	0.000906	0.00469	CcSEcCtD
Fingolimod—Infestation—Etoposide—uterine cancer	0.000906	0.00469	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000883	0.00458	CcSEcCtD
Fingolimod—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000882	0.00457	CcSEcCtD
Fingolimod—Leukopenia—Dactinomycin—uterine cancer	0.000875	0.00454	CcSEcCtD
Fingolimod—Atrioventricular block—Doxorubicin—uterine cancer	0.000866	0.00449	CcSEcCtD
Fingolimod—CYP3A4—female reproductive system—uterine cancer	0.000813	0.00299	CbGeAlD
Fingolimod—Asthenia—Progesterone—uterine cancer	0.00081	0.0042	CcSEcCtD
Fingolimod—CYP2D6—female reproductive system—uterine cancer	0.0008	0.00294	CbGeAlD
Fingolimod—Pruritus—Progesterone—uterine cancer	0.000799	0.00414	CcSEcCtD
Fingolimod—Infection—Dactinomycin—uterine cancer	0.000793	0.00411	CcSEcCtD
Fingolimod—Diarrhoea—Progesterone—uterine cancer	0.000772	0.004	CcSEcCtD
Fingolimod—Eye disorder—Etoposide—uterine cancer	0.00076	0.00394	CcSEcCtD
Fingolimod—Cardiac disorder—Etoposide—uterine cancer	0.000754	0.00391	CcSEcCtD
Fingolimod—Dizziness—Progesterone—uterine cancer	0.000747	0.00387	CcSEcCtD
Fingolimod—Angiopathy—Etoposide—uterine cancer	0.000738	0.00382	CcSEcCtD
Fingolimod—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000734	0.00381	CcSEcCtD
Fingolimod—Eczema—Epirubicin—uterine cancer	0.000733	0.0038	CcSEcCtD
Fingolimod—Mediastinal disorder—Etoposide—uterine cancer	0.000733	0.0038	CcSEcCtD
Fingolimod—Eye pain—Epirubicin—uterine cancer	0.00073	0.00378	CcSEcCtD
Fingolimod—CYP2D6—female gonad—uterine cancer	0.000728	0.00267	CbGeAlD
Fingolimod—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000724	0.00375	CcSEcCtD
Fingolimod—Alopecia—Etoposide—uterine cancer	0.000718	0.00372	CcSEcCtD
Fingolimod—Headache—Progesterone—uterine cancer	0.000707	0.00367	CcSEcCtD
Fingolimod—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.0007	0.00363	CcSEcCtD
Fingolimod—Fatigue—Dactinomycin—uterine cancer	0.000688	0.00357	CcSEcCtD
Fingolimod—Back pain—Etoposide—uterine cancer	0.000685	0.00355	CcSEcCtD
Fingolimod—Eczema—Doxorubicin—uterine cancer	0.000678	0.00352	CcSEcCtD
Fingolimod—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000677	0.00351	CcSEcCtD
Fingolimod—Eye pain—Doxorubicin—uterine cancer	0.000675	0.0035	CcSEcCtD
Fingolimod—Cerebrovascular accident—Epirubicin—uterine cancer	0.000672	0.00348	CcSEcCtD
Fingolimod—Migraine—Epirubicin—uterine cancer	0.000648	0.00336	CcSEcCtD
Fingolimod—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000641	0.00332	CcSEcCtD
Fingolimod—Leukopenia—Etoposide—uterine cancer	0.000633	0.00328	CcSEcCtD
Fingolimod—Cardiac arrest—Epirubicin—uterine cancer	0.000626	0.00325	CcSEcCtD
Fingolimod—Cerebrovascular accident—Doxorubicin—uterine cancer	0.000622	0.00322	CcSEcCtD
Fingolimod—Cough—Etoposide—uterine cancer	0.000618	0.0032	CcSEcCtD
Fingolimod—Hypertension—Etoposide—uterine cancer	0.000611	0.00317	CcSEcCtD
Fingolimod—Liver function test abnormal—Epirubicin—uterine cancer	0.000608	0.00315	CcSEcCtD
Fingolimod—Migraine—Doxorubicin—uterine cancer	0.0006	0.00311	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000598	0.0031	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.000593	0.00307	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000581	0.00301	CcSEcCtD
Fingolimod—Cardiac arrest—Doxorubicin—uterine cancer	0.00058	0.003	CcSEcCtD
Fingolimod—Infection—Etoposide—uterine cancer	0.000574	0.00297	CcSEcCtD
Fingolimod—Asthenia—Dactinomycin—uterine cancer	0.000573	0.00297	CcSEcCtD
Fingolimod—Influenza—Epirubicin—uterine cancer	0.000569	0.00295	CcSEcCtD
Fingolimod—Liver function test abnormal—Doxorubicin—uterine cancer	0.000563	0.00292	CcSEcCtD
Fingolimod—Skin disorder—Etoposide—uterine cancer	0.000561	0.00291	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000549	0.00285	CcSEcCtD
Fingolimod—Bronchitis—Epirubicin—uterine cancer	0.000548	0.00284	CcSEcCtD
Fingolimod—Diarrhoea—Dactinomycin—uterine cancer	0.000546	0.00283	CcSEcCtD
Fingolimod—Hypotension—Etoposide—uterine cancer	0.00054	0.0028	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000538	0.00279	CcSEcCtD
Fingolimod—Influenza—Doxorubicin—uterine cancer	0.000527	0.00273	CcSEcCtD
Fingolimod—Paraesthesia—Etoposide—uterine cancer	0.000519	0.00269	CcSEcCtD
Fingolimod—Weight decreased—Epirubicin—uterine cancer	0.000515	0.00267	CcSEcCtD
Fingolimod—Dyspnoea—Etoposide—uterine cancer	0.000515	0.00267	CcSEcCtD
Fingolimod—Pneumonia—Epirubicin—uterine cancer	0.000511	0.00265	CcSEcCtD
Fingolimod—Infestation NOS—Epirubicin—uterine cancer	0.000508	0.00263	CcSEcCtD
Fingolimod—Infestation—Epirubicin—uterine cancer	0.000508	0.00263	CcSEcCtD
Fingolimod—Bronchitis—Doxorubicin—uterine cancer	0.000507	0.00263	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Etoposide—uterine cancer	0.000499	0.00258	CcSEcCtD
Fingolimod—Fatigue—Etoposide—uterine cancer	0.000498	0.00258	CcSEcCtD
Fingolimod—Weight decreased—Doxorubicin—uterine cancer	0.000477	0.00247	CcSEcCtD
Fingolimod—Sinusitis—Epirubicin—uterine cancer	0.000476	0.00247	CcSEcCtD
Fingolimod—Pneumonia—Doxorubicin—uterine cancer	0.000472	0.00245	CcSEcCtD
Fingolimod—Infestation NOS—Doxorubicin—uterine cancer	0.00047	0.00243	CcSEcCtD
Fingolimod—Infestation—Doxorubicin—uterine cancer	0.00047	0.00243	CcSEcCtD
Fingolimod—Bradycardia—Epirubicin—uterine cancer	0.000464	0.0024	CcSEcCtD
Fingolimod—Connective tissue disorder—Epirubicin—uterine cancer	0.000448	0.00232	CcSEcCtD
Fingolimod—Sinusitis—Doxorubicin—uterine cancer	0.000441	0.00228	CcSEcCtD
Fingolimod—Bradycardia—Doxorubicin—uterine cancer	0.000429	0.00223	CcSEcCtD
Fingolimod—Eye disorder—Epirubicin—uterine cancer	0.000426	0.00221	CcSEcCtD
Fingolimod—Cardiac disorder—Epirubicin—uterine cancer	0.000423	0.00219	CcSEcCtD
Fingolimod—Asthenia—Etoposide—uterine cancer	0.000414	0.00215	CcSEcCtD
Fingolimod—Connective tissue disorder—Doxorubicin—uterine cancer	0.000414	0.00215	CcSEcCtD
Fingolimod—Angiopathy—Epirubicin—uterine cancer	0.000413	0.00214	CcSEcCtD
Fingolimod—Mediastinal disorder—Epirubicin—uterine cancer	0.000411	0.00213	CcSEcCtD
Fingolimod—Pruritus—Etoposide—uterine cancer	0.000409	0.00212	CcSEcCtD
Fingolimod—Alopecia—Epirubicin—uterine cancer	0.000403	0.00209	CcSEcCtD
Fingolimod—Mental disorder—Epirubicin—uterine cancer	0.000399	0.00207	CcSEcCtD
Fingolimod—Diarrhoea—Etoposide—uterine cancer	0.000395	0.00205	CcSEcCtD
Fingolimod—Eye disorder—Doxorubicin—uterine cancer	0.000394	0.00204	CcSEcCtD
Fingolimod—Cardiac disorder—Doxorubicin—uterine cancer	0.000391	0.00203	CcSEcCtD
Fingolimod—Back pain—Epirubicin—uterine cancer	0.000384	0.00199	CcSEcCtD
Fingolimod—Angiopathy—Doxorubicin—uterine cancer	0.000383	0.00198	CcSEcCtD
Fingolimod—Dizziness—Etoposide—uterine cancer	0.000382	0.00198	CcSEcCtD
Fingolimod—Mediastinal disorder—Doxorubicin—uterine cancer	0.00038	0.00197	CcSEcCtD
Fingolimod—Vision blurred—Epirubicin—uterine cancer	0.000374	0.00194	CcSEcCtD
Fingolimod—Alopecia—Doxorubicin—uterine cancer	0.000373	0.00193	CcSEcCtD
Fingolimod—Mental disorder—Doxorubicin—uterine cancer	0.000369	0.00191	CcSEcCtD
Fingolimod—Headache—Etoposide—uterine cancer	0.000362	0.00188	CcSEcCtD
Fingolimod—Leukopenia—Epirubicin—uterine cancer	0.000355	0.00184	CcSEcCtD
Fingolimod—Back pain—Doxorubicin—uterine cancer	0.000355	0.00184	CcSEcCtD
Fingolimod—Palpitations—Epirubicin—uterine cancer	0.000351	0.00182	CcSEcCtD
Fingolimod—Cough—Epirubicin—uterine cancer	0.000346	0.00179	CcSEcCtD
Fingolimod—Vision blurred—Doxorubicin—uterine cancer	0.000346	0.00179	CcSEcCtD
Fingolimod—Hypertension—Epirubicin—uterine cancer	0.000342	0.00178	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000335	0.00174	CcSEcCtD
Fingolimod—Leukopenia—Doxorubicin—uterine cancer	0.000329	0.0017	CcSEcCtD
Fingolimod—Palpitations—Doxorubicin—uterine cancer	0.000324	0.00168	CcSEcCtD
Fingolimod—Infection—Epirubicin—uterine cancer	0.000322	0.00167	CcSEcCtD
Fingolimod—Cough—Doxorubicin—uterine cancer	0.00032	0.00166	CcSEcCtD
Fingolimod—Nervous system disorder—Epirubicin—uterine cancer	0.000317	0.00165	CcSEcCtD
Fingolimod—Hypertension—Doxorubicin—uterine cancer	0.000317	0.00164	CcSEcCtD
Fingolimod—Skin disorder—Epirubicin—uterine cancer	0.000314	0.00163	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.00031	0.00161	CcSEcCtD
Fingolimod—Hypotension—Epirubicin—uterine cancer	0.000303	0.00157	CcSEcCtD
Fingolimod—Infection—Doxorubicin—uterine cancer	0.000298	0.00154	CcSEcCtD
Fingolimod—Nervous system disorder—Doxorubicin—uterine cancer	0.000294	0.00152	CcSEcCtD
Fingolimod—Skin disorder—Doxorubicin—uterine cancer	0.000291	0.00151	CcSEcCtD
Fingolimod—Paraesthesia—Epirubicin—uterine cancer	0.000291	0.00151	CcSEcCtD
Fingolimod—Dyspnoea—Epirubicin—uterine cancer	0.000289	0.0015	CcSEcCtD
Fingolimod—Hypotension—Doxorubicin—uterine cancer	0.00028	0.00145	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000279	0.00145	CcSEcCtD
Fingolimod—Fatigue—Epirubicin—uterine cancer	0.000279	0.00145	CcSEcCtD
Fingolimod—Paraesthesia—Doxorubicin—uterine cancer	0.000269	0.00139	CcSEcCtD
Fingolimod—Dyspnoea—Doxorubicin—uterine cancer	0.000267	0.00138	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000259	0.00134	CcSEcCtD
Fingolimod—Fatigue—Doxorubicin—uterine cancer	0.000258	0.00134	CcSEcCtD
Fingolimod—SPHK1—Metabolism of proteins—CCL2—uterine cancer	0.00024	0.00094	CbGpPWpGaD
Fingolimod—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.00024	0.000939	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—YWHAE—uterine cancer	0.000237	0.000929	CbGpPWpGaD
Fingolimod—CYP2D6—Metapathway biotransformation—AKR1C1—uterine cancer	0.000236	0.000923	CbGpPWpGaD
Fingolimod—Asthenia—Epirubicin—uterine cancer	0.000232	0.0012	CcSEcCtD
Fingolimod—CYP4F2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	0.00023	0.000901	CbGpPWpGaD
Fingolimod—Pruritus—Epirubicin—uterine cancer	0.000229	0.00119	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—FBXW7—uterine cancer	0.000228	0.000891	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—STK11—uterine cancer	0.000228	0.000891	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—CCL2—uterine cancer	0.000227	0.000887	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	0.000226	0.000885	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—AKR1C3—uterine cancer	0.000226	0.000885	CbGpPWpGaD
Fingolimod—Diarrhoea—Epirubicin—uterine cancer	0.000222	0.00115	CcSEcCtD
Fingolimod—SPHK1—Signaling Pathways—PGR—uterine cancer	0.00022	0.000862	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	0.000219	0.000859	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—STK11—uterine cancer	0.000219	0.000858	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—STK11—uterine cancer	0.000219	0.000858	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—CCL2—uterine cancer	0.000218	0.000854	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—CCL2—uterine cancer	0.000218	0.000854	CbGpPWpGaD
Fingolimod—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000218	0.000853	CbGpPWpGaD
Fingolimod—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000215	0.000841	CbGpPWpGaD
Fingolimod—Asthenia—Doxorubicin—uterine cancer	0.000215	0.00111	CcSEcCtD
Fingolimod—Dizziness—Epirubicin—uterine cancer	0.000214	0.00111	CcSEcCtD
Fingolimod—CYP4F12—Metabolism—MTHFR—uterine cancer	0.000213	0.000835	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—SOCS3—uterine cancer	0.000213	0.000834	CbGpPWpGaD
Fingolimod—Pruritus—Doxorubicin—uterine cancer	0.000212	0.0011	CcSEcCtD
Fingolimod—SPHK1—Metabolism—STK11—uterine cancer	0.000211	0.000824	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—CYP19A1—uterine cancer	0.000211	0.000824	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	0.00021	0.000822	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—YWHAE—uterine cancer	0.00021	0.000822	CbGpPWpGaD
Fingolimod—CYP2D6—Metapathway biotransformation—GPX3—uterine cancer	0.000207	0.000811	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—SOCS3—uterine cancer	0.000205	0.000803	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—SOCS3—uterine cancer	0.000205	0.000803	CbGpPWpGaD
Fingolimod—Diarrhoea—Doxorubicin—uterine cancer	0.000205	0.00106	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—CDKN2B—uterine cancer	0.000204	0.000799	CbGpPWpGaD
Fingolimod—Headache—Epirubicin—uterine cancer	0.000203	0.00105	CcSEcCtD
Fingolimod—CYP2E1—Biological oxidations—CYP19A1—uterine cancer	0.000202	0.000791	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—FBXW7—uterine cancer	0.000201	0.000789	CbGpPWpGaD
Fingolimod—CYP2E1—Metapathway biotransformation—CYP19A1—uterine cancer	0.000199	0.00078	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—STK11—uterine cancer	0.000199	0.000779	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—IGF1R—uterine cancer	0.000198	0.000776	CbGpPWpGaD
Fingolimod—Dizziness—Doxorubicin—uterine cancer	0.000198	0.00103	CcSEcCtD
Fingolimod—S1PR1—Signaling by GPCR—CCL2—uterine cancer	0.000198	0.000775	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	0.000198	0.000774	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—CXCL8—uterine cancer	0.000197	0.000772	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CDKN2B—uterine cancer	0.000196	0.000769	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CDKN2B—uterine cancer	0.000196	0.000769	CbGpPWpGaD
Fingolimod—CYP2D6—Biological oxidations—CYP11A1—uterine cancer	0.000195	0.000763	CbGpPWpGaD
Fingolimod—CYP2D6—Metapathway biotransformation—CYP11A1—uterine cancer	0.000192	0.000753	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—IGF1R—uterine cancer	0.000191	0.000747	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—IGF1R—uterine cancer	0.000191	0.000747	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of proteins—CXCL8—uterine cancer	0.00019	0.000744	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—CXCL8—uterine cancer	0.00019	0.000743	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—CXCL8—uterine cancer	0.00019	0.000743	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	0.000189	0.000738	CbGpPWpGaD
Fingolimod—Headache—Doxorubicin—uterine cancer	0.000188	0.000973	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—SOCS3—uterine cancer	0.000186	0.000729	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—SMAD3—uterine cancer	0.000186	0.000729	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—MTHFR—uterine cancer	0.000184	0.000721	CbGpPWpGaD
Fingolimod—CYP2D6—Metapathway biotransformation—AKR1C3—uterine cancer	0.000182	0.000711	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—SMAD3—uterine cancer	0.000179	0.000702	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—SMAD3—uterine cancer	0.000179	0.000702	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—CXCL8—uterine cancer	0.000179	0.000701	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CDKN2B—uterine cancer	0.000178	0.000698	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—FGFR2—uterine cancer	0.000178	0.000696	CbGpPWpGaD
Fingolimod—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000177	0.000691	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—STK11—uterine cancer	0.000176	0.000689	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of proteins—CTNNB1—uterine cancer	0.000175	0.000686	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—IGF1R—uterine cancer	0.000173	0.000678	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—CXCL8—uterine cancer	0.000172	0.000675	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—CXCL8—uterine cancer	0.000172	0.000675	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—CXCL8—uterine cancer	0.000172	0.000675	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—FGFR2—uterine cancer	0.000171	0.00067	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—FGFR2—uterine cancer	0.000171	0.00067	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—SOCS3—uterine cancer	0.000165	0.000645	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—SMAD3—uterine cancer	0.000163	0.000637	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	0.000162	0.000635	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—MTHFR—uterine cancer	0.000158	0.000619	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CDKN2B—uterine cancer	0.000158	0.000618	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—CXCL8—uterine cancer	0.000157	0.000613	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—FGFR2—uterine cancer	0.000155	0.000608	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	0.000154	0.000604	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—IGF1R—uterine cancer	0.000153	0.0006	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—ESR1—uterine cancer	0.000152	0.000595	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—ESR1—uterine cancer	0.000146	0.000573	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—ESR1—uterine cancer	0.000146	0.000573	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—SMAD3—uterine cancer	0.000144	0.000564	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—NRAS—uterine cancer	0.000144	0.000563	CbGpPWpGaD
Fingolimod—CYP2D6—Biological oxidations—CYP19A1—uterine cancer	0.000143	0.000562	CbGpPWpGaD
Fingolimod—CYP2D6—Metapathway biotransformation—CYP19A1—uterine cancer	0.000141	0.000554	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	0.000139	0.000546	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—NRAS—uterine cancer	0.000138	0.000541	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—NRAS—uterine cancer	0.000138	0.000541	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—FGFR2—uterine cancer	0.000137	0.000538	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	0.000135	0.00053	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CCL2—uterine cancer	0.000134	0.000524	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—ESR1—uterine cancer	0.000133	0.00052	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CCL2—uterine cancer	0.000129	0.000504	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CCL2—uterine cancer	0.000129	0.000504	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	0.000127	0.000499	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	0.000126	0.000492	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—NRAS—uterine cancer	0.000126	0.000492	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—PIK3CA—uterine cancer	0.000125	0.00049	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—KRAS—uterine cancer	0.000124	0.000484	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—PIK3CA—uterine cancer	0.00012	0.000472	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—PIK3CA—uterine cancer	0.00012	0.000472	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—KRAS—uterine cancer	0.000119	0.000466	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—KRAS—uterine cancer	0.000119	0.000466	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	0.000119	0.000465	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—PTEN—uterine cancer	0.000119	0.000465	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—ESR1—uterine cancer	0.000118	0.00046	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CCL2—uterine cancer	0.000117	0.000458	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—PIK3CA—uterine cancer	0.000114	0.000445	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—EP300—uterine cancer	0.000113	0.000443	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—ERBB2—uterine cancer	0.000112	0.000437	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—PIK3CA—uterine cancer	0.000109	0.000428	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—PIK3CA—uterine cancer	0.000109	0.000428	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—PIK3CA—uterine cancer	0.000109	0.000428	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—SRD5A2—uterine cancer	0.000109	0.000425	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—NDUFB11—uterine cancer	0.000109	0.000425	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—KRAS—uterine cancer	0.000108	0.000423	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—ERBB2—uterine cancer	0.000107	0.00042	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—ERBB2—uterine cancer	0.000107	0.00042	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CXCL8—uterine cancer	0.000106	0.000414	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—HRAS—uterine cancer	0.000105	0.000412	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CCL2—uterine cancer	0.000104	0.000405	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CDKN1B—uterine cancer	0.000103	0.000405	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PTEN—uterine cancer	0.000102	0.000401	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—AKT1—uterine cancer	0.000102	0.0004	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CXCL8—uterine cancer	0.000102	0.000399	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CXCL8—uterine cancer	0.000102	0.000399	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—HRAS—uterine cancer	0.000101	0.000396	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—HRAS—uterine cancer	0.000101	0.000396	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CDKN1B—uterine cancer	9.95e-05	0.000389	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CDKN1B—uterine cancer	9.95e-05	0.000389	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—PIK3CA—uterine cancer	9.93e-05	0.000389	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—AKT1—uterine cancer	9.84e-05	0.000385	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—AKT1—uterine cancer	9.84e-05	0.000385	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—EP300—uterine cancer	9.77e-05	0.000382	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CTNNB1—uterine cancer	9.76e-05	0.000382	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—ERBB2—uterine cancer	9.75e-05	0.000382	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—PTEN—uterine cancer	9.52e-05	0.000372	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CTNNB1—uterine cancer	9.4e-05	0.000368	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CTNNB1—uterine cancer	9.4e-05	0.000368	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	9.38e-05	0.000367	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—AKT1—uterine cancer	9.28e-05	0.000363	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	9.25e-05	0.000362	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CXCL8—uterine cancer	9.25e-05	0.000362	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—HRAS—uterine cancer	9.19e-05	0.00036	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—PTEN—uterine cancer	9.16e-05	0.000359	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—PTEN—uterine cancer	9.16e-05	0.000359	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—EP300—uterine cancer	9.07e-05	0.000355	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CDKN1B—uterine cancer	9.03e-05	0.000354	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—AKT1—uterine cancer	8.94e-05	0.00035	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—AKT1—uterine cancer	8.94e-05	0.00035	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—AKT1—uterine cancer	8.94e-05	0.00035	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PTEN—uterine cancer	8.8e-05	0.000345	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—EP300—uterine cancer	8.74e-05	0.000342	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—EP300—uterine cancer	8.74e-05	0.000342	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—ERBB2—uterine cancer	8.63e-05	0.000338	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—VEGFA—uterine cancer	8.59e-05	0.000336	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CTNNB1—uterine cancer	8.53e-05	0.000334	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—NRAS—uterine cancer	8.49e-05	0.000332	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—EP300—uterine cancer	8.4e-05	0.000329	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—PIK3CA—uterine cancer	8.37e-05	0.000328	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—PTEN—uterine cancer	8.32e-05	0.000326	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—VEGFA—uterine cancer	8.27e-05	0.000324	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—VEGFA—uterine cancer	8.27e-05	0.000324	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CXCL8—uterine cancer	8.19e-05	0.00032	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—NRAS—uterine cancer	8.17e-05	0.00032	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—NRAS—uterine cancer	8.17e-05	0.00032	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—AKT1—uterine cancer	8.11e-05	0.000318	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CDKN1B—uterine cancer	7.99e-05	0.000313	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—EP300—uterine cancer	7.93e-05	0.00031	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—AKR1B1—uterine cancer	7.85e-05	0.000307	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—STAR—uterine cancer	7.85e-05	0.000307	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—NDUFB11—uterine cancer	7.71e-05	0.000302	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—SRD5A2—uterine cancer	7.71e-05	0.000302	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CTNNB1—uterine cancer	7.55e-05	0.000296	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—VEGFA—uterine cancer	7.51e-05	0.000294	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—NRAS—uterine cancer	7.42e-05	0.00029	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PTEN—uterine cancer	7.36e-05	0.000288	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—KRAS—uterine cancer	7.31e-05	0.000286	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PIK3CA—uterine cancer	7.23e-05	0.000283	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—KRAS—uterine cancer	7.03e-05	0.000275	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—KRAS—uterine cancer	7.03e-05	0.000275	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—EP300—uterine cancer	7.02e-05	0.000275	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—AKT1—uterine cancer	6.84e-05	0.000268	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—PIK3CA—uterine cancer	6.71e-05	0.000263	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—VEGFA—uterine cancer	6.65e-05	0.00026	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—NRAS—uterine cancer	6.57e-05	0.000257	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—TP53—uterine cancer	6.49e-05	0.000254	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—PIK3CA—uterine cancer	6.46e-05	0.000253	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—PIK3CA—uterine cancer	6.46e-05	0.000253	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—KRAS—uterine cancer	6.39e-05	0.00025	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—TP53—uterine cancer	6.25e-05	0.000245	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—TP53—uterine cancer	6.25e-05	0.000245	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—HRAS—uterine cancer	6.21e-05	0.000243	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PIK3CA—uterine cancer	6.21e-05	0.000243	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—POLD1—uterine cancer	6.16e-05	0.000241	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—HRAS—uterine cancer	5.98e-05	0.000234	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—HRAS—uterine cancer	5.98e-05	0.000234	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—AKT1—uterine cancer	5.91e-05	0.000231	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—PIK3CA—uterine cancer	5.87e-05	0.00023	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—AKR1C1—uterine cancer	5.76e-05	0.000226	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TP53—uterine cancer	5.68e-05	0.000222	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—KRAS—uterine cancer	5.65e-05	0.000221	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—AKR1B1—uterine cancer	5.57e-05	0.000218	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—STAR—uterine cancer	5.57e-05	0.000218	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—AKT1—uterine cancer	5.48e-05	0.000215	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—HRAS—uterine cancer	5.43e-05	0.000212	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—AKT1—uterine cancer	5.28e-05	0.000207	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—AKT1—uterine cancer	5.28e-05	0.000207	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PIK3CA—uterine cancer	5.19e-05	0.000203	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—RRM2—uterine cancer	5.14e-05	0.000201	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—AKT1—uterine cancer	5.07e-05	0.000199	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—NDUFB11—uterine cancer	5.04e-05	0.000197	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SRD5A2—uterine cancer	5.04e-05	0.000197	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TP53—uterine cancer	5.02e-05	0.000197	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—DCN—uterine cancer	4.99e-05	0.000195	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—HRAS—uterine cancer	4.8e-05	0.000188	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—AKT1—uterine cancer	4.79e-05	0.000188	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CYP11A1—uterine cancer	4.7e-05	0.000184	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—AKR1C3—uterine cancer	4.44e-05	0.000174	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—POLD1—uterine cancer	4.37e-05	0.000171	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—AKT1—uterine cancer	4.24e-05	0.000166	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—AKR1C1—uterine cancer	4.09e-05	0.00016	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—RRM2—uterine cancer	3.65e-05	0.000143	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—AKR1B1—uterine cancer	3.64e-05	0.000143	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—STAR—uterine cancer	3.64e-05	0.000143	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—DCN—uterine cancer	3.54e-05	0.000139	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CYP19A1—uterine cancer	3.46e-05	0.000135	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—STK11—uterine cancer	3.46e-05	0.000135	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYP11A1—uterine cancer	3.33e-05	0.000131	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—AKR1C3—uterine cancer	3.15e-05	0.000123	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—POLD1—uterine cancer	2.86e-05	0.000112	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—AKR1C1—uterine cancer	2.67e-05	0.000105	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—MTHFR—uterine cancer	2.6e-05	0.000102	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—STK11—uterine cancer	2.45e-05	9.6e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYP19A1—uterine cancer	2.45e-05	9.6e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—RRM2—uterine cancer	2.38e-05	9.33e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—DCN—uterine cancer	2.31e-05	9.06e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYP11A1—uterine cancer	2.18e-05	8.53e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—AKR1C3—uterine cancer	2.06e-05	8.06e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—MTHFR—uterine cancer	1.84e-05	7.22e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYP19A1—uterine cancer	1.6e-05	6.28e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—STK11—uterine cancer	1.6e-05	6.28e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PTEN—uterine cancer	1.45e-05	5.66e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—EP300—uterine cancer	1.38e-05	5.39e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—MTHFR—uterine cancer	1.21e-05	4.72e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PTEN—uterine cancer	1.03e-05	4.01e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PIK3CA—uterine cancer	1.02e-05	3.99e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—EP300—uterine cancer	9.78e-06	3.83e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—AKT1—uterine cancer	8.33e-06	3.26e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PIK3CA—uterine cancer	7.23e-06	2.83e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PTEN—uterine cancer	6.7e-06	2.62e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—EP300—uterine cancer	6.39e-06	2.5e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—AKT1—uterine cancer	5.91e-06	2.31e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PIK3CA—uterine cancer	4.73e-06	1.85e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—AKT1—uterine cancer	3.86e-06	1.51e-05	CbGpPWpGaD
